| ²é¿´: 420 | »Ø¸´: 0 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
rennai315ͳæ (СÓÐÃûÆø)
|
[½»Á÷]
2ÐÍÌÇÄò²¡Ïà¹Ø»ùÒò¶¨Î»Ñо¿
|
||
|
2ÐÍÌÇÄò²¡µÄ·¢²¡»úÖÆÖÁ½ñÈÔ²»ÉõÃ÷ÁË£¬µ«Á÷Ðв¡Ñ§Ñо¿ÏÔʾÆäÖØÒªµÄÒÅ´«±³¾°£¬ÇÒÆäÒÅ´«·½Ê½·ûºÏ¶à»ùÒò²¡ÒÅ´«Ä£Ê½£¬¼´Óжà¸ö»ùÒò²ÎÓëÁË2ÐÍÌÇÄò²¡µÄ·¢ÉúºÍ·¢Õ¹£¬ÕýÒòΪÆäÒÅ´«·½Ê½²»·ûºÏ¾µäµÄÃϵ¶ûÒÅ´«¹æÂÉ£¬Òò¶ø¸ø2ÐÍÌÇÄò²¡Ïà¹Ø»ùÒòµÄÑо¿´øÀ´Á˺ܴóµÄÀ§ÄÑ¡£Ëæ×ÅÈËÀà»ùÒò×鼯»®ÊµÊ©ºÍÏÖ´úÒÅ´«Ñ§¼¼Êõ·¢Õ¹£¬Ò»´óÅúDNAÒÅ´«±êÖ¾ÔÚȾɫÌåÉϵõ½¾«È·¶¨Î»ÒÔ¼°¿ìËÙ¸ßЧµÄÁ¬Ëø·ÖÎöÈí¼þµÄ³öÏÖ£¬Ê¹ÈËÃÇÓпÉÄÜͨ¹ýÒ»ÖÖȫеIJßÂÔ¨D»ùÓÚ»ùÒò×éɨÃèµÄ¶¨Î»¿Ë¡·½·¨À´Ñо¿2ÐÍÌÇÄò²¡µÄÏà¹Ø»ùÒò¡£ ÖÁ½ñΪֹ£¬ÈÔÎÞÖйúÈ˼°ÑÇÖÞÈËȺ2ÐÍÌÇÄò²¡»ùÒò×éɨÃèµÄ±¨µÀ£¬±¾ÎÄÊ×´ÎÔÚ¹ú¼ÊÉϱ¨µÀÁËÖйúºº×åÈË2ÐÍÌÇÄò²¡Ò׸лùÒòλµã¡£ ͨ¹ýÊÕ¼¯´óÁ¿2ÐÍÌÇÄò²¡»¼²¡Í¬°û¶Ô¼Òϵ£¬ÀûÓÃÈËÀà¶à̬ÐÔÑо¿ÖÐÐĹ«²¼µÄ΢ÎÀÐÇλµã£¬¶ÔÕâЩ¼Òϵ½øÐÐÈ«»ùÒò×éɨÃèºÍÁ¬Ëø·ÖÎö£¬ÒÔÆÚÕÒ³ö2ÐÍÌÇÄò²¡Ïà¹Ø»ùÒòËùÔÚµÄȾɫÌåÇøÓò¡£ÕÒ³öD9S175λµã¸½½üºòÑ¡»ùÒòÔÚÖйúÈËȺÖеĵ¥ºËÜÕËá¶à̬ÐÔ£¬²¢Ì½ÌÖÆäÓë2ÐÍÌÇÄò²¡µÄ¹ØÏµ¡£ ¶Ô102¸ö»ª¶«µØÇøºº×åÈË2ÐÍÌÇÄò²¡¼Òϵ£¬ÆäÖаüÀ¨ÌÇÄò²¡»¼Õß282ÈË£¬74¸ö¼ÒϵÓÐ2¸öÌÇÄò²¡Í¬°û£¬18¸ö¼ÒϵÓÐ3¸öÌÇÄò²¡Í¬°û£¬10¸ö¼ÒϵÓÐ4¸öÌÇÄò²¡Í¬°û£¬ÀûÓÃPerkin-ElmerÉúÎï¼¼Êõ²¿ÌṩµÄÓ«¹â±ê¼ÇµÄ΢ÎÀÐÇλµãÒýÎï³ÉÌ×ÊÔ¼ÁºÐ£¬¹²247΢ÎÀÐÇλµã£¬½øÐÐÈ«»ùÒò×éɨÃ裬²¢·Ö±ðÀûÓ÷DzÎÊý·ÖÎö¼°²ÎÊý·ÖÎöÈí¼þGENEHUNTERºÍMLINK½øÐÐÁ¬Ëø·ÖÎö£¬ÕÒ³öȾɫÌåÉÏÓë2ÐÍÌÇÄò²¡Á¬ËøµÄλµã¼°ÇøÓò¡£¶ÔD9S175λµã¸½½üµÄ²¿·ÖºòÑ¡»ùÒòµÄ5¡¯ÉÏÓεĵ÷¿ØÐòÁС¢ÍâÏÔ×ÓÒÔ¼°ÓëÍâÏÔ×Ó½ôÁÚµÄÄÚº¬×ÓÇøÓòµÄÐòÁÐÓÃË«Ïò²âÐò·¨½øÐÐSNP¼ì²â£¬SNPɸ²éÖ÷Ҫͨ¹ýPolyPhredÈí¼þ½øÐУ¬²¢Í¨¹ý2ÐÍÌÇÄò²¡»¼ÕßµÄÑùÆ·³ØÓëÕý³£¶ÔÕÕÈËȺDNAÑùÆ·³ØµÄSNPλµãµÄ·å¸ß±È³õ²½¹À¼Æ¸ÃλµãµÈλ»ùÒòÔÚÁ½×éÈËȺÖеķֲ¼ÆµÂÊ¡£ È«»ùÒò×éɨÃè½á¹ûÏÔʾ9ºÅȾɫÌåÉÏD9S171ºÍD9S175ͬ2ÐÍÌÇÄò²¡ÓÐÁ¬ËøÇãÏò£¬Æä·Ç²ÎÊý·ÖÎöͳ¼ÆÁ¿Zall-score ·Ö±ðΪ3.28624ºÍ2.93932£¬ÆäÏàÓ¦µÄPÖµ·Ö±ðΪ1.19¡Á10£4ºÍ4.73¡Á10£4£¬²ÎÊý·ÖÎö½á¹ûÒ²ÏÔʾÀàËÆµÄ½á¹û£¬ÆäLod-score·Ö±ðΪ4.612133ºÍ4.288642£¬PÖµ·Ö±ðΪ2.44¡ä10£5 ºÍ5.14¡ä10£5¡£´ËÍ⣬¶Ô2ÐÍÌÇÄò²¡°´ÌåÖØÖ¸Êý½øÐзÖ×éºó·¢ÏÖ£¬µÍÌåÖØÖ¸Êý×éÔÚ20ºÅȾɫÌåÉÏD20S196λµãͬ2ÐÍÌÇÄò²¡ÓнÏÇ¿Á¬ËøÇãÏò£¬ÆäNPL-score´Ó1.52ÉÏÉýÖÁ2.92£¬¶øPÖµÔò´Ó0.04Ͻµµ½6.53¡Á10£4¡£ÁíÍâ»ùÒò×éÖÐÉÐÓжà¸öλµã¼°È¾É«ÌåÇøÓòÏÔʾͬ2ÐÍÌÇÄò²¡³Ê½ÏÈõµÄÁ¬ËøÇãÏò¡£ ÆäÖÐ9ºÅȾɫÌåÉϵÄD9S171ºÍD9S175Á½¸öλµã¼°Æä¸½½üµÄÇøÓò¿ÉÄÜ´æÔÚ2ÐÍÌÇÄò²¡Ò׸лùÒò£¬¸ù¾ÝGENETHON¹«²¼µÄÈËÀàÒÅ´«Ñ§Í¼Æ×£¬ÕâÁ½¸öλµã·Ö±ð¾à9ºÅȾɫÌå¶Ì±ÛÄ©¶Ë42cM¼°62.8cM¡£×î½ü£¬ÔÚÆäËüÈËȺÖУ¬Ò²·¢ÏÖÕâÁ½¸öλµã¸½½üµÄÇøÓòͬ2ÐÍÌÇÄò²¡»òÆäÏà¹ØÖ¸±êÁ¬Ëø¡£ÕâЩ½á¹ûÌáʾ9ºÅȾɫÌåÉÏ¿ÉÄÜ´æÔÚ×Ų»Í¬ÖÖ×å¼°ÈËȺ¹²ÓеÄ2ÐÍÌÇÄò²¡Ò׸лùÒò¡£´ÓºòÑ¡»ùÒò½Ç¶È¿´£¬9q13-21ÇøÓòÖÐÒ²´æÔÚ×ÅÒ»Ð©ÖØÒªµÄºòÑ¡»ùÒò£¬ÈçX25»ùÒò£¬¸Ã»ùÒò±àÂëÒ»ÃûΪfrataxinµÄÏßÁ£Ìåµ°°×£¬ÕâÖÖµ°°×±í´ïÁ¿¼õÉÙ¿ÉÒýÆðÒ»ÖÖÉÙ¼ûµÄÒÅ´«ÐÔ¼²²¡¨D¨DFreidriech¹²¼Ãʧµ÷£¬ÕâÖÖ¼²²¡µÄ»¼Õß³£°éÓÐÌÇ´úлÎÉÂÒ£¬Ñо¿·¢ÏÖX25»ùÒòµÄµÚÒ»¸öÄÚº¬×ÓGAAÖØ¸´ÐòÁеĴ¿ºÏÀ©Ôö¿ÉÒýÆðÕâÖÖ¼²²¡£¬Õý³£ÈËX25»ùÒòµÄµÚÒ»¸öÄÚº¬×ÓGAAÖØ¸´ÐòÁпÉÓÐ9´ÎÒÔϵÄÖØ¸´£¬¶øFreidriech¹²¼Ãʧµ÷»¼ÕßÖØ¸´´ÎÊý¿É´ïµ½100ÖÁ200´ÎÉõÖÁ¸ü¶à¡£¸ÃÖØ¸´ÐòÁÐÖеȳ̶ȵÄÀ©Ôö(10¡«40´Î)¿ÉÒýÆðÌÇ´úлÎÉÂÒ¶øÓÖ²»ÖÁÓÚÒýÆð¹²¼Ãʧµ÷£¬Òò¶øÍ¬2ÐÍÌÇÄò²¡³ÊÏÔÖøÏà¹Ø¡£µ«X25»ùÒòÊÇ·ñÊÇÖйúºº×åÈË2ÐÍÌÇÄò²¡Ò׸лùÒò£¬»¹ÓдýÓÚ½øÒ»²½ÑéÖ¤¡£ ÁíÒ»¸öÖµµÃÒ»ÌáµÄ·¢ÏÖÊÇ2ºÅȾɫÌ峤±Û½üÄ©¶Ë´¦D2S126ÏÔʾͬ2ÐÍÌÇÄò²¡Á¬Ëø¿ÉÄÜ(PֵΪ0.008)¡£ÊÂʵÉÏ£¬ÔÚD2S126¸½½ü»¹ÓÐÁ½¸öÖØÒªµÄºòÑ¡»ùÒò£¬Ò»¸öÊÇNEUROD1£¬¸Ã»ùÒò±àÂëµÄµ°°×ͬHLHµ°°×E47ÐγÉÒì¶þ¾ÛÌåºó£¬¿ÉͬÒȵºËØ»ùÒòÆô¶¯×ÓÉϵÄE-boxÐòÁнáºÏ£¬´Ó¶øµ÷¿ØÒȵºËصķÖÃÚ£¬MaleckiµÈÈË·¢ÏÖ£¬¸Ã»ùÒòµÄÔÓºÏÍ»±äͬ2ÐÍÌÇÄò²¡Ïà¹Ø£»ÁíÒ»¸öÖØÒªµÄºòÑ¡»ùÒòΪÒȵºËØÊÜÌåµ×Îï1»ùÒò£¬¸Ã»ùÒò±àÂëµÄµ°°×ÖÊÔÚÒȵºËØÐźÅתµ¼¹ý³ÌÖÐÆðÖØÒª×÷Óã¬Ñо¿·¢ÏÖ£¬¸Ã»ùÒòµÄÄ³Ð©ÌØÊâµÈλ»ùÒòͬ2ÐÍÌÇÄò²¡Ïà¹Ø£¬Òò´Ë£¬2ºÅȾɫÌ峤±Û½üÄ©¶Ë´¦¿ÉÄÜÊÇÒýÆð2ÐÍÌÇÄò²¡Ò׸ÐÐÔµÄÒ»¸öÖØÒªÇøÓò¡£ ÓÉÓÚ2ÐÍÌÇÄò²¡ÊÇÒ»ÖÖÒìÖÊÐÔ½ÏÇ¿µÄ¸´ÔÓÐÔ×´¼²²¡£¬Í¬ÑùÊdzٷ¢ÐÍ2ÐÍÌÇÄò²¡»¼Õߣ¬ÆäÒ׸лùÒòÔÚ²»Í¬¼ÒϵÖпÉÄÜÓÐËù²»Í¬£¬Òò¶ø½«Óɲ»Í¬Ò׸лùÒòÒýÆðµÄÌÇÄò²¡µÄ¼ÒϵºÏÔÚÒ»Æð½øÐÐÁ¬Ëø·ÖÎö£¬ÓÐʱ·´¶ø»á½µµÍÑôÐÔλµãµÄLod-score£¬Ôì³É¼ÙÒõÐÔ½á¹û£¬¶øÍ¨¹ýÁÙ´²±íÐͶԼÒϵ½øÐÐһЩ³õ²½µÄ·ÖÀ࣬¿É½µµÍ¼ÒϵµÄÒìÖÊÐԳ̶ȣ¬´Ó¶ø½µµÍ¼ÙÒõÐÔ½á¹û¡£Ñо¿½á¹ûÌáʾ£¬ÔÚ¶à»ùÒò¼²²¡Ò׸лùÒòÑо¿ÖУ¬°´Ä³Ð©ÖмäÐÔ×´¶ÔÑо¿¶ÔÏó½øÐзÖ×éºó£¬¿ÉÌá¸ß»ùÒò×éɨÃè¶ÔÑôÐÔλµã¼ì²âµÄÁéÃô¶È¡£Òò¶øÎÒÃÇÔÚÍê³ÉÁË102¸ö¼ÒϵµÄÈ«»ùÒò×éɨÃèºó£¬ÓÖ¶ÔÕâЩ¼Òϵ°´·¢²¡ÄêÁä¼°ÌåÖØÖ¸Êý½øÐзÖ×飬²¢¶Ô¸÷×éÖØÐ½øÐÐÁ¬Ëø·ÖÎö¡£ÎÒÃÇÖ®ËùÒÔÑ¡Ôñ·¢²¡ÄêÁä¼°ÌåÖØÖ¸Êý½øÐзÖ×飬¶øÎ´Ñ¡ÔñÈçÒȵºËØ·ÖÃÚˮƽ¼°ÒȵºËصֿ¹³Ì¶ÈµÈÀíÂÛÉϸü¼ÓÖ±½ÓµÄÖмäÐÔ×´£¬ÊÇÒòΪÕâЩָ±êÊÜÆäËüÒòËØÓ°Ïì½Ï¶à£¬ÈçѪÌÇˮƽ¡¢¼²²¡³ÖÐøÊ±¼äÒÔ¼°ÓÃÒ©Çé¿öµÈ¶¼»áÓ°ÏìÒȵºËØ·ÖÃÚ¼°ÒȵºËØ×÷Ó㬶ø·¢²¡ÄêÁä¼°ÌåÖØÖ¸ÊýÔòÊÜÆäËüÒòËØÓ°Ïì½ÏС£¬Òò¶ø¸ü¿Í¹Û¶ø×¼È·¡£½á¹û£¬°´·¢²¡ÄêÁä·Ö×éºó£¬²¢Î´·¢ÏÖеÄÑôÐÔλµã£¬µ«°´ÌåÖØÖ¸Êý·Ö×éºóÔò·¢ÏÖµÍÌåÖØÖ¸Êý×éÖУ¬D20S196λµãµÄNPL-scoreÓÉÔÀ´µÄ1.5ÉÏÉýµ½2.9£¬pÖµÓÉÔÀ´µÄ0.04Ͻµµ½6¡Á10£4£¬Ç¿ÁÒÌáʾ¸Ãλµãͬ2ÐÍÌÇÄò²¡Á¬Ëø£¬ÔÚ±¾´ÎÑо¿ÖУ¬ÎÒÃÇÊÇÒÔÌåÖØÖ¸Êý23kg/m2À´½øÐзÖ×é¶ø·Çͨ³£µÄ25 kg/m2Õâ¸öÇø·Ö·ÊÅÖÓë·Ç·ÊÅÖÈËȺµÄ±ê×¼¡£ÎÒÃǵÄÑо¿½á¹û±íÃ÷ÔÚ¸ÃλµãËùÔÚµÄÇøÓò¿ÉÄÜÓÐij¸öÓëµÍÌåÖØÖ¸ÊýÏà¹ØµÄ»ùÒò(¿ÉÄÜÊÇÒýÆðÒȵºËØ·ÖÃÚ²»×ãµÄ»ùÒò)ÒýÆðÁË2ÐÍÌÇÄò²¡Ò׸ÐÐÔµÄÔö¼Ó£¬ÊÂʵÉÏ£¬D20S196ËùÔÚµÄÇøÓò(20q13.3)Ò²ÊÇĿǰ¹ú¼ÊÉϱ¨µÀ½Ï¶àµÄͬ2ÐÍÌÇÄò²¡Á¬ËøµÄÇøÓòÖ®Ò»£¬ÒÑÓÐÖÁÉÙ4¸öС×鱨µÀÁ˸ÃÇøÓòͬ2ÐÍÌÇÄò²¡Á¬Ëø£¬¾¡¹ÜÆä¾ßÌåλÖÃÂÔÓв»Í¬£»ÁíÍ⣬´ÓºòÑ¡»ùÒò½Ç¶ÈÀ´¿´£¬20ºÅȾɫÌåÉÏÒ²´æÔÚ×Ŷà¸öÖØÒªµÄÌÇÄò²¡ºòÑ¡»ùÒò£¬Èç¾à¶Ì±ÛÄ©¶ËÔ¼65cMµÄHNF£4¦Á(MODY1)£¬ËüÊǺËÊÜÌ峬¼Ò×å³ÉÔ±Ö®Ò»£¬ÊÇÒ»ÖÖת¼Òò×Ó£¬ÔÚ½«Ï¸°ûÍâÐźŴ«µÝµ½Ï¸°ûÄÚÒýÆð»ùÒòת¼¸Ä±äµÄ¹ý³ÌÖÐÆðÖØÒª×÷Ó㬴ËÍ⣬¾à¶Ì±ÛÄ©¶Ë87£100cMµÄPCK»ùÒòÒ²ÊÇÒ»¸öÖØÒªµÄºòÑ¡»ùÒò£¬ËüÊÇÌÇÒìÉú¹ý³ÌÖеÄÏÞËÙø֮һ¡£20ºÅȾɫÌ峤±ÛÉÏÉÐÓÐÁíÍ⼸¸öÖØÒªµÄºòÑ¡»ùÒò£ºagouti signaling protein¡¢HNF-3¦Â(ËüÃÇ·Ö±ð¾à¶Ì±ÛÄ©¶Ë53.5-58.9cM¼°¡«50cM)ÒÔ¼°Á×֬øC£G1ºÍCCAATÔöÇ¿×Ó½áºÏµ°°×B (ÕâÁ½¸ö»ùÒò¾ùλÓÚ¾à¶Ì±ÛÄ©¶ËÔ¼70cMµÄÇøÓòÖÐ)¡£ÊóµÄagouti»ùÒòÍ»±ä¿ÉÒýÆð·ÊÅÖÏà¹ØµÄ2ÐÍÌÇÄò²¡£¬Æä»úÖÆ¿ÉÄÜΪ¹Ç÷À¼¡ÖиÆÀë×ÓͨµÀµÄ¸Ä±ä£»HNF-3¦Â¿Éµ÷½ÚHNF-4¦ÁºÍHNF-1¦Á»ùÒòµÄ±í´ï£»PLCG1»ùÒò±àÂëÒ»ÔÚϸ°ûÄÚÐźÅתµ¼¹ý³ÌÖÐÆð×÷ÓõĵڶþÐÅʹµ°°×£»C/EBP-¦Â»ùÒòÔò±àÂëһת¼Òò×Ó£¬Õâ¸öת¼Òò×ÓÔÚ¸Îϸ°ûÖÐcAMPÓÕµ¼µÄPCK1»ùÒòµÄ±í´ï¹ý³ÌÖÐÆð×ÅÖØÒªµÄ×÷ÓᣠÔÚD9S175λµã¸½½ü¹²Ñ¡È¡4¸ö»ùÒò½øÐмì²â£¬ËüÃÇ·Ö±ðΪRORB¡¢FLJ20808¡¢FLJ20087¡¢FRDA£¬¹²·¢ÏÖ9¸öSNP£¬ÆäÖÐ2¸öλÓÚ5¡¯µ÷¿ØÇøÓò¡¢1¸öλÓÚ3¡¯·Ç·ÒëÇø¡¢2¸öλÓÚÍâÏÔ×ÓÇøÓò¡¢4¸öλÓÚÓëÍâÏÔ×ӽϽüµÄÄÚº¬×ÓÇøÓò£¬ÕâЩSNPÖÐ8¸öSNPÔÚ»¼ÕßÑùÆ·³ØºÍÕý³£¶ÔÕÕÑùÆ·³ØÖÐÆµÂÊ·Ö²¼ÎÞÃ÷ÏÔ²îÒ죬½öRORBI9-59ÔÚ»¼ÕßÑùÆ·³ØºÍÕý³£¶ÔÕÕÑùÆ·³ØÖÐÆµÂÊ·Ö²¼ÓÐÃ÷ÏÔ²îÒì(´ïµ½60%ÒÔÉÏ)£¬¸ÃSNPλÓÚRORB»ùÒòµÚ9¸öÄÚº¬×ÓÖС£ ±¾´ÎʵÑéÔÚ4¸öºòÑ¡»ùÒòÖй²¼ì²âÁËÔ¼12kb³¤¶ÈµÄDNAƬ¶Ï£¬½á¹ûÕÒµ½9¸öSNP£¬ÆäÖÐ2¸öλÓÚ3¡¯ÉÏÓεĵ÷¿ØÐòÁУ¬1¸öλÓÚ3¡¯·Ç·ÒëÇø£¬2¸öλÓÚÍâÏÔ×Ó£¬4¸öλÓÚ½ôÁÚÍâÏÔ×ÓÁ½²àµÄÄÚº¬×ÓÇøÓò£¬Æ½¾ù1.3kb³öÏÖ1¸öSNP£¬ÂÔµÍÓÚ»ùÒò×éÖÐSNP³öÏֵį½¾ùƵÂÊ(Ô¼500¡«1000bp³öÏÖ1¸ö)£¬ÕâÖ÷ÒªÊÇÒòΪÎÒÃÇËùÑ¡µÄ¼ì²âÇøÓò¶àΪÊÜÑ¡ÔñѹÁ¦½Ï´óµÄÍâÏÔ×Ó¼°ÓëÆä½ôÁÚµÄÄÚº¬×ÓÇøÓò¡£ÕâЩSNPÖÐ8¸öSNPµÄµÈλ»ùÒòƵÂÊÔÚ¼²²¡ÑùÆ·³ØºÍ¶ÔÕÕ×éÑùÆ·³ØÎÞÃ÷ÏÔ²îÒ죬ֻÓÐÒ»¸öSNP(RORBI9-59)ÆäµÈλ»ùÒòƵÂÊÔÚ¼²²¡ÑùÆ·³ØºÍ¶ÔÕÕ×éÑùÆ·³ØÖвîÒ쳬¹ý15%£¬´ïµ½60%ÒÔÉÏ£¬Ìáʾ¸ÃSNP¿ÉÄܺÍ2ÐÍÌÇÄò²¡Ïà¹Ø£¬¸ÃSNPλÓÚRORB»ùÒòµÚ9¸öÄÚº¬×ÓÖУ¬¾àµÚ9¸öÍâÏÔ×Ó59bp¡£RORB»ùÒòÈ«³ÆÎªRAR-related orphan receptor B£¬ÊÇÒ»ÖÖת¼Òò×Ó£¬ÎªÏ¸°ûºËÊÜÌå¼Ò×å³ÉÔ±Ö®Ò»£¬RARÊÜÌå¿ÉÓë¶àÖÖºËÊÜÌåÐγɶþ¾ÛÌå²¢Æðµ½ÐźÅתµ¼×÷Óã¬ËüÒ²ÄܺÍRXR¾ºÕù½áºÏPPARG£¬´Ó¶øÒÖÖÆºóÕßµÄÐźÅתµ¼£¬µ«RORBµÄ¹¦ÄÜÉв»Çå³ý£¬Ð¡ÊóÖÐת»ùÒò¼°»ùÒòÌÞ³ýÊÔÑéҲδ·¢ÏָûùÒòͬÌÇ´úлÓйء£ÓÉÓÚĿǰÎÒÃÇÉÐδ¶Ô¸ÃSNP½øÐдóÑù±¾Á¿µÄ»ùÒò·ÖÐͺÍÏà¹Ø·ÖÎö£¬Òò´ËÉÐÄѶ϶¨ËüÊÇ·ñͬ2ÐÍÌÇÄò²¡Ïà¹Ø¡£ ¹Ø¼ü´Ê£º2ÐÍÌÇÄò²¡ Ò׸лùÒò »ùÒò×éɨÃè µ¥ºËÜÕËá¶à̬ÐÔ The Positional Study Of Type 2 Diabetes Related Genes Abstract Part I Genome-Wide Search for Type 2 Diabetes Susceptibility Genes in Chinese Hans Aims: To search the type 2 diabetes susceptibility genes in Chinese population. Methods: A genome-wide scan was performed using both parametric and non-parametric linkage analyses. 102 families (478 family members) from Chinese Hans residing in the East and South-East China, including 282 diabetic patients, among them 74 families with 2 affected siblings, 18 families with 3 affected siblings and 10 families with 4 siblings. 247 fluorescence labeled microsatellite markers, with an average resolution of 15cM, were amplified. Genehunter and Mlink of Linkage package were used for the non-parametric and parametric linkage analyses. Results: Two loci on chromosome 9 D9S171 and D9S175 showed suggestive evidence for linkage, with Zall-score of 3.29 and 2.94 respectively, and p-value of 1.19¡ä10-4 and 4.73¡ä10-4. The corresponding Lod-score of these two loci were 4.61 and 4.29 respectively with the p-value of 2.44¡ä10-5 and 5.14¡ä10-5, under additive model. A locus on the long arm of chromosome 20 D20S196 showed a rise of Zall-score (from 1.52 to 2.92) and a corresponding decrease of p-value from 0.04 to 6.53¡ä10-4 when families with lower BMI were analyzed alone. Other loci with weaker evidence for linkage were also observed. Conclusions: Our results suggest that chromosome 9 may contain genes involved in the susceptibility to type 2 diabetes in East and Southeast Chinese Han population, while chromosome 20 may hide genes that were linked to type 2 diabetes in families with lower BMI. Other regions may also hide susceptibility genes with minor effect, but further investigation is required to confirm the results. Part II Study on the single nucleotide polymorphism(SNP) of candidate genes near D9S175 Aims: To find out SNPs of candidate genes near D9S175 in Chinese population and study their relationship with type 2 diabetes. Methods: Bidirectional sequencing was used to detect SNPs in the 5¡¯regulatory regions, exons and partial introns close to exons of some candidate genes near D9S175. PolyPhred was used to detect SNPs in individual samples. A preliminary estimation of the distribution of alleles in diabetic population and normal control population was performed using the comparison of the ratio of pic-height of DNA pool of diabetic patients and that of normal controls. Results: Four genes near D9S175 were screened for SNPs, they were RORB, FLJ20808, FLJ20087 and FRDA. 9 SNPs were discovered, among them 2 in 5¡¯ regulatory region, 1 in 5¡¯ UTR, 2 in exons and 4 in introns close to exons. The distribution of alleles was significantly different between the DNA pool of diabetic patients and that of normal control subjects only in RORBI9-59, the SNP in the 9th intron of RORB gene. Conclusion: SNP related to type 2 diabetes may exist in RORB gene, but the conclusion need to be confirmed with genotyping and association study in large samples. Key Words: type 2 diabetes, susceptibility gene, genome-wide scan, single nucleotide polymorphism |
» ²ÂÄãϲ»¶
Ë«Ëõëå·´Ó¦×Éѯ
ÒѾÓÐ1È˻ظ´
305ҽѧÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
Ƥ·ô¼°Æä¸½ÊôÆ÷ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ51È˻ظ´
Çóµ÷¼ÁÕëÍÆÑ§Ë¶
ÒѾÓÐ10È˻ظ´
ÖÐÒ½335µ÷¼Á
ÒѾÓÐ0È˻ظ´
Çóµ÷¼Á ½ÓÊÜ¿çרҵ
ÒѾÓÐ0È˻ظ´
±±ÖÐÒ½²©µ¼ÍƼö
ÒѾÓÐ17È˻ظ´
»úÖÆ¼Ù˵ͼ
ÒѾÓÐ3È˻ظ´
105300³õÊÔ320Çóµ÷¼Á£¡
ÒѾÓÐ0È˻ظ´
1053¹«¹²ÎÀÉú³õÊÔ320Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)















»Ø¸´´ËÂ¥